vs
CIVISTA BANCSHARES, INC.（CIVB）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是CIVISTA BANCSHARES, INC.的1.6倍（$75.5M vs $47.3M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 11.3%）
Civista Bancshares Inc.是一家总部位于美国的银行控股公司，主要在中西部地区运营，面向零售客户、本地中小企业及社区群体提供个人与商业银行服务，包括存款账户、各类贷款产品及财富管理解决方案。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
CIVB vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.6倍
$47.3M
两年增速更快
PBYI
近两年复合增速
11.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $47.3M | $75.5M |
| 净利润 | $15.0M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | — | 22.7% |
| 净利率 | 31.7% | — |
| 营收同比 | — | 27.7% |
| 净利润同比 | 47.4% | — |
| 每股收益（稀释后） | $0.72 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CIVBPBYI
| Q1 26 | $47.3M | — | ||
| Q4 25 | $46.3M | $75.5M | ||
| Q3 25 | $44.2M | $54.5M | ||
| Q2 25 | $41.4M | $52.4M | ||
| Q1 25 | $40.6M | $46.0M | ||
| Q4 24 | $40.4M | $59.1M | ||
| Q3 24 | $39.3M | $80.5M | ||
| Q2 24 | $38.1M | $47.1M |
净利润CIVBPBYI
| Q1 26 | $15.0M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $12.8M | $8.8M | ||
| Q2 25 | $11.0M | $5.9M | ||
| Q1 25 | $10.2M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $8.4M | $20.3M | ||
| Q2 24 | $7.1M | $-4.5M |
毛利率CIVBPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% |
营业利润率CIVBPBYI
| Q1 26 | — | — | ||
| Q4 25 | 31.8% | 22.7% | ||
| Q3 25 | 35.4% | 17.6% | ||
| Q2 25 | 31.1% | 12.7% | ||
| Q1 25 | 29.4% | 8.7% | ||
| Q4 24 | 28.2% | 22.6% | ||
| Q3 24 | 25.2% | 27.4% | ||
| Q2 24 | 21.2% | -4.6% |
净利率CIVBPBYI
| Q1 26 | 31.7% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 28.9% | 16.2% | ||
| Q2 25 | 26.6% | 11.2% | ||
| Q1 25 | 25.0% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 21.3% | 25.2% | ||
| Q2 24 | 18.5% | -9.6% |
每股收益（稀释后）CIVBPBYI
| Q1 26 | $0.72 | — | ||
| Q4 25 | $0.59 | $0.26 | ||
| Q3 25 | $0.68 | $0.17 | ||
| Q2 25 | $0.71 | $0.12 | ||
| Q1 25 | $0.66 | $0.06 | ||
| Q4 24 | $0.62 | $0.40 | ||
| Q3 24 | $0.53 | $0.41 | ||
| Q2 24 | $0.45 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $553.9M | $130.3M |
| 总资产 | $4.3B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资CIVBPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M |
总债务CIVBPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M |
股东权益CIVBPBYI
| Q1 26 | $553.9M | — | ||
| Q4 25 | $543.5M | $130.3M | ||
| Q3 25 | $499.0M | $115.3M | ||
| Q2 25 | $404.1M | $104.7M | ||
| Q1 25 | $397.4M | $97.1M | ||
| Q4 24 | $388.5M | $92.1M | ||
| Q3 24 | $394.4M | $71.1M | ||
| Q2 24 | $373.8M | $48.5M |
总资产CIVBPBYI
| Q1 26 | $4.3B | — | ||
| Q4 25 | $4.3B | $216.3M | ||
| Q3 25 | $4.1B | $202.9M | ||
| Q2 25 | $4.2B | $194.9M | ||
| Q1 25 | $4.1B | $196.2M | ||
| Q4 24 | $4.1B | $213.3M | ||
| Q3 24 | $4.1B | $220.7M | ||
| Q2 24 | $4.0B | $205.0M |
负债/权益比CIVBPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流CIVBPBYI
| Q1 26 | — | — | ||
| Q4 25 | $43.3M | $14.4M | ||
| Q3 25 | $19.0M | $9.7M | ||
| Q2 25 | $11.1M | $14.1M | ||
| Q1 25 | $3.6M | $3.6M | ||
| Q4 24 | $48.2M | $15.6M | ||
| Q3 24 | $12.9M | $11.0M | ||
| Q2 24 | $12.2M | $1.0M |
自由现金流CIVBPBYI
| Q1 26 | — | — | ||
| Q4 25 | $42.1M | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | $3.5M | $3.6M | ||
| Q4 24 | $44.1M | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M |
自由现金流率CIVBPBYI
| Q1 26 | — | — | ||
| Q4 25 | 90.9% | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | 8.5% | 7.7% | ||
| Q4 24 | 109.1% | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% |
资本支出强度CIVBPBYI
| Q1 26 | — | — | ||
| Q4 25 | 2.5% | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | 0.4% | 0.1% | ||
| Q4 24 | 10.4% | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% |
现金转化率CIVBPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.49× | 1.10× | ||
| Q2 25 | 1.01× | 2.41× | ||
| Q1 25 | 0.36× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.54× | 0.54× | ||
| Q2 24 | 1.73× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CIVB
| Net Interest Income | $37.8M | 80% |
| Noninterest Income | $9.4M | 20% |
PBYI
暂无分部数据
